NO943762L - Indolderivater som 5-HT 1 agonister - Google Patents

Indolderivater som 5-HT 1 agonister

Info

Publication number
NO943762L
NO943762L NO943762A NO943762A NO943762L NO 943762 L NO943762 L NO 943762L NO 943762 A NO943762 A NO 943762A NO 943762 A NO943762 A NO 943762A NO 943762 L NO943762 L NO 943762L
Authority
NO
Norway
Prior art keywords
agonists
indole derivatives
indole
derivatives
Prior art date
Application number
NO943762A
Other languages
English (en)
Other versions
NO943762D0 (no
NO303388B1 (no
Inventor
John E Macor
Martin J Wythes
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO943762L publication Critical patent/NO943762L/no
Publication of NO943762D0 publication Critical patent/NO943762D0/no
Publication of NO303388B1 publication Critical patent/NO303388B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO943762A 1992-04-07 1994-10-06 Indolderivater, farmas°ytisk preparat inneholdende dem og mellomprodukter ved fremstilling av dem NO303388B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86473792A 1992-04-07 1992-04-07
PCT/US1993/001967 WO1993020073A1 (en) 1992-04-07 1993-03-10 Indole derivatives as 5-ht1 agonists

Publications (3)

Publication Number Publication Date
NO943762L true NO943762L (no) 1994-10-06
NO943762D0 NO943762D0 (no) 1994-10-06
NO303388B1 NO303388B1 (no) 1998-07-06

Family

ID=25343950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943762A NO303388B1 (no) 1992-04-07 1994-10-06 Indolderivater, farmas°ytisk preparat inneholdende dem og mellomprodukter ved fremstilling av dem

Country Status (26)

Country Link
US (7) US5747501A (no)
EP (1) EP0635017A1 (no)
JP (1) JP2644088B2 (no)
KR (1) KR0179072B1 (no)
CN (2) CN1050841C (no)
AU (1) AU670579B2 (no)
BR (1) BR9306201A (no)
CA (1) CA2133413C (no)
CZ (1) CZ281763B6 (no)
EG (1) EG20226A (no)
FI (1) FI931558A (no)
HR (1) HRP930752A2 (no)
HU (1) HUT64062A (no)
IL (1) IL105206A (no)
MX (1) MX9302011A (no)
MY (1) MY108909A (no)
NO (1) NO303388B1 (no)
NZ (1) NZ251086A (no)
PL (1) PL172405B1 (no)
RU (1) RU2101283C1 (no)
SK (1) SK280193B6 (no)
TW (1) TW341565B (no)
UA (1) UA27467C2 (no)
WO (1) WO1993020073A1 (no)
YU (1) YU48931B (no)
ZA (1) ZA932440B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
PL172405B1 (en) * 1992-04-07 1997-09-30 Pfizer Derivatives of indole
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
KR100191973B1 (ko) * 1993-08-31 1999-06-15 디. 제이. 우드, 스피겔 알렌 제이 5-아릴인돌 유도체
WO1995032196A1 (en) * 1994-05-19 1995-11-30 Merck Sharp & Dohme Limited Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
GB9415575D0 (en) * 1994-08-02 1994-09-21 Merck Sharp & Dohme Therapeutic agents
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
WO1996017842A1 (en) * 1994-12-06 1996-06-13 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
ES2196163T3 (es) * 1995-07-31 2003-12-16 Shionogi & Co Derivados de pirrolidina con una actividad de inhibicion de la fosfolipasa a2.
GB9519558D0 (en) * 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
US6051593A (en) * 1997-06-20 2000-04-18 Sugen, Inc. 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors
CA2334897A1 (en) * 1998-06-30 2000-01-06 Eli Lilly And Company Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
US6355672B1 (en) * 1998-08-07 2002-03-12 Takeda Chemical Industries, Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US7041697B2 (en) * 2002-09-12 2006-05-09 Wyeth Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
CA2635010A1 (en) * 2005-12-30 2007-07-19 Amjad Ali Oxazolidinone derivatives as cetp inhibitors
WO2010043396A1 (en) * 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US20100217013A1 (en) * 2008-12-15 2010-08-26 Wenge Li Enantioselective process for the preparation of zolmitriptan
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神***病を処置するための方法および組成物
US10793548B2 (en) * 2016-04-28 2020-10-06 Jiangsu Hengrui Medicine Co., Ltd. Method for preparing tyrosine kinase inhibitor and derivative thereof
MX2022009528A (es) * 2020-02-04 2022-11-14 Mindset Pharma Inc Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc.

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
US4689336A (en) * 1981-01-02 1987-08-25 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine 2,4-diones
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
FR2601008B1 (fr) * 1986-07-03 1990-03-30 Sanofi Sa Procede de synthese stereospecifique de derives de l'indole
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
IL98392A (en) * 1990-06-07 1996-01-19 Wellcome Found History of indole, their preparation and the pharmaceutical preparations containing them
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
RU2095360C1 (ru) * 1990-10-15 1997-11-10 Пфайзер Инк. Производные индола, их оптические изомеры и фармацевтически приемлемые соли
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
TW263508B (no) * 1991-02-12 1995-11-21 Pfizer
UA41297C2 (uk) 1991-11-25 2001-09-17 Пфайзер, Інк. Похідні індолу, фармацевтична композиція і спосіб лікування
CA2083891A1 (en) * 1991-12-03 1993-06-04 Angus Murray Macleod Heterocyclic compounds, compositions containing them and their use in therapy
US5409941A (en) 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
TW288010B (no) 1992-03-05 1996-10-11 Pfizer
PL172405B1 (en) * 1992-04-07 1997-09-30 Pfizer Derivatives of indole
DE69307875T2 (de) 1992-04-10 1997-05-22 Pfizer Acylaminoindolderivate als 5-ht1 agonisten

Also Published As

Publication number Publication date
US6465500B1 (en) 2002-10-15
YU23893A (sh) 1996-10-09
CN1050841C (zh) 2000-03-29
RU2101283C1 (ru) 1998-01-10
US5747501A (en) 1998-05-05
WO1993020073A1 (en) 1993-10-14
IL105206A (en) 1999-04-11
KR950700906A (ko) 1995-02-20
CA2133413A1 (en) 1993-10-14
CN1083443C (zh) 2002-04-24
US6387937B1 (en) 2002-05-14
AU3789893A (en) 1993-11-08
AU670579B2 (en) 1996-07-25
HUT64062A (en) 1993-11-29
PL172405B1 (en) 1997-09-30
EG20226A (en) 1997-12-31
UA27467C2 (uk) 2000-09-15
CN1082543A (zh) 1994-02-23
SK280193B6 (sk) 1999-09-10
FI931558A (fi) 1993-10-08
CZ281763B6 (cs) 1997-01-15
US6410739B1 (en) 2002-06-25
JPH07504919A (ja) 1995-06-01
CZ246494A3 (en) 1995-06-14
YU48931B (sh) 2002-12-10
HRP930752A2 (en) 1994-10-31
TW341565B (en) 1998-10-01
MY108909A (en) 1996-11-30
HU9301003D0 (en) 1993-06-28
CA2133413C (en) 2001-04-10
BR9306201A (pt) 1998-06-23
ZA932440B (en) 1994-10-05
EP0635017A1 (en) 1995-01-25
RU94045897A (ru) 1996-09-10
FI931558A0 (fi) 1993-04-06
MX9302011A (es) 1994-03-31
NZ251086A (en) 1996-09-25
KR0179072B1 (ko) 1999-03-20
NO943762D0 (no) 1994-10-06
US6150388A (en) 2000-11-21
NO303388B1 (no) 1998-07-06
SK120694A3 (en) 1995-05-10
IL105206A0 (en) 1993-07-08
US6387941B1 (en) 2002-05-14
CN1225362A (zh) 1999-08-11
US6436957B1 (en) 2002-08-20
JP2644088B2 (ja) 1997-08-25

Similar Documents

Publication Publication Date Title
NO943762L (no) Indolderivater som 5-HT 1 agonister
FI944805A (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
DK0393936T3 (da) 3-substituerede 2-oxindolderivater som antiinflammatoriske midler
DE69610822T2 (de) Indolderivate als 5-ht rezeptorantagoniste
FI970310A0 (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
DK43193A (da) Indolderivater
NO934800D0 (no) Anvendelse av tetrahydrokarbazonderivater som 5HT1-reseptoragonis ter
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
NO963117D0 (no) Indol-derivater som 5-HT1-agonister
NO893078D0 (no) Indolderivater.
DK0411150T3 (da) Indolderivater
DE69212058D1 (de) Indol-Derivate
NO954287D0 (no) Anvendelse av indolderivater som 5-HT1 agonister
DE59005241D1 (de) Indolderivate.
NO985970D0 (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
DE69320653T2 (de) Tetrahydrocarbazolderivate als 5-ht1-ähnliche agonisten
FI953361A (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
MA23795A1 (fr) Derives d'indole substitues
DK0660715T3 (da) Carbostyrilderivater som antiarytmiske midler
DK0944601T3 (da) Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
DK0851856T3 (da) Indolderivater som melatoninerge analoger
FI951047A (fi) Menetelmä indolijohdannaisten valmistamiseksi
NO951299D0 (no) Polyaminderivater som anti-cytomegalovirale midler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees